Author: Customer Service

ROUYN-NORANDA, Québec, March 31, 2026 (GLOBE NEWSWIRE) — Chibougamau Independent Mines Inc. (CBG-TSX-V in Canada, CLL1-Frankfurt, Stuttgart, Berlin and Lang & Schwarz Stock Exchanges in Germany, CMAUF-OTC in the US), herein called Chibougamau, is pleased to report to shareholders that TomaGold Corporation (LOT-TSXV, TOGOF-OTCPK) has started a drill program to extend 5 recent drill holes in order to intersect a newly recently discovered zinc/gold/silver zone intersected beneath the previously known Berrigan mineralized zone. The Berrigan property is a part of a large land package under option from Chibougamau Independent Mines as announced in a press release dated August 14, 2023 and accessible here. The five drill hole extensions are planned to intersect the horizon where previous drill hole TOM-25-015 intersected 5.08% Zn...

Voltalia strengthens its financial flexibility with the support of its main shareholder as part of the acceleration of the SPRING planSigning of a 100 million euros regulated agreement Voltalia (Euronext Paris, code ISIN: FR0011995588), an international player in renewable energies, publishes the signing of a regulated agreement entered into pursuant to Articles L.221013 and R.221019 of the French Commercial Code. On the occasion of the presentation of its annual results on March 12, 2026, Voltalia announced an acceleration of its SPRING transformation plan, structured around several levers: the refocusing on the company’s core activities, the clarification of its operating model, the sustainable improvement of performance which will also allow a return to greater financial agility by reducing its debt level. This trajectory is based...

Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) — PatentVest today released its latest PatentVest Pulse report, “The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine.” The report provides a comprehensive analysis of the rapidly evolving amylin drug landscape, a mechanism once considered commercially unviable that is now at the center of global pharmaceutical strategy. Over the past eighteen months, more than $19 billion in deal value has been committed across the amylin space, with major pharmaceutical companies, including Novo Nordisk, Eli Lilly, Roche, Pfizer, and AbbVie, actively building positions. The report highlights:Nearly 40 amylin receptor agonist programs currently in development worldwide The first GLP-1/amylin combination therapy approaching FDA decision Clinical...

Availability of the Universal Registration Document 2025 Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energy, today announces the publication of its Universal Registration Document 2025 Voltalia announces that it has filed with the Autorité des Marchés Financiers and made available to the public its Universal Registration Document (period from 1 January 2025 to 31 December 2025) under the number D26-0181. The Universal Registration Document includes the following information:the Annual Financial Report; the Management Report including the sustainability report; the Statutory Auditors’ reports and information on their fees; the Board of Directors’ report on Corporate Governance; and information on the share buy-back programme.The Universal Registration Document is available on...